Literature DB >> 17704791

Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation.

G Michel1, P Bordigoni, M-C Simeoni, C Curtillet, S Hoxha, S Robitail, I Thuret, S Pall-Kondolff, H Chambost, D Orbicini, P Auquier.   

Abstract

We compared late side effects and quality of life (QoL) in 430 survivors of childhood acute leukaemia based on whether they had undergone haematopoietic cell transplantation (n=142) or not (n=288). Mean age was 18.2 years and mean follow-up duration was 11.9 years. Multivariate logistic regression analyses were performed to compare the risk of each type of late effect in the two groups. Based on age, VSP-A or SF36 questionnaires were used to assess QoL. For each QoL dimension, multiple linear regression was done to construct models of association with the treatment group. Transplanted patients experienced more side effects, including height growth failure, gonadal dysfunction, hypothyroidism and cataract. Children and adolescents in the two treatment groups reported similar QoL levels for almost all dimensions except a better perception of school work by young transplanted children and more difficulties in relating to the medical staff for transplanted adolescents. In adults, two differences in physical domain of QoL were detected but the calculated effect sizes were less than 0.2 in each case, suggesting an uncertain clinical significance. In spite of a higher risk of physical adverse events in the transplanted group, very few clinically significant differences in QoL are detectable.

Entities:  

Mesh:

Year:  2007        PMID: 17704791     DOI: 10.1038/sj.bmt.1705821

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

Review 1.  Quality of life in survivors of childhood cancer: a systematic review of the literature (2001-2008).

Authors:  Janette McDougall; Miranda Tsonis
Journal:  Support Care Cancer       Date:  2009-06-02       Impact factor: 3.603

2.  Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study.

Authors:  Melissa M Hudson; Kirsten K Ness; Vikki G Nolan; Gregory T Armstrong; Daniel M Green; E Brannon Morris; Sheri L Spunt; Monika L Metzger; Kevin R Krull; James L Klosky; Deo Kumar Srivastava; Leslie L Robison
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

3.  NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.

Authors:  Susan K Parsons; Sean Phipps; Lillian Sung; K Scott Baker; Michael A Pulsipher; Kirsten K Ness
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-10       Impact factor: 5.742

4.  Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.

Authors:  Claire Oudin; Pascal Auquier; Yves Bertrand; Philippe Chastagner; Justyna Kanold; Maryline Poirée; Sandrine Thouvenin; Stephane Ducassou; Dominique Plantaz; Marie-Dominique Tabone; Jean-Hugues Dalle; Virginie Gandemer; Patrick Lutz; Anne Sirvent; Virginie Villes; Vincent Barlogis; André Baruchel; Guy Leverger; Julie Berbis; Gérard Michel
Journal:  Haematologica       Date:  2016-03-11       Impact factor: 9.941

5.  Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study.

Authors:  C Oudin; P Auquier; Y Bertrand; A Contet; J Kanold; N Sirvent; S Thouvenin; M-D Tabone; P Lutz; S Ducassou; D Plantaz; J-H Dalle; V Gandemer; S Beliard; J Berbis; C Vercasson; V Barlogis; A Baruchel; G Leverger; G Michel
Journal:  Bone Marrow Transplant       Date:  2015-07-20       Impact factor: 5.483

Review 6.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

Authors:  Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

7.  Patient-reported outcomes in survivors of childhood hematologic malignancies with hematopoietic stem cell transplant.

Authors:  Hsiu-Ju Yen; Hesham M Eissa; Neel S Bhatt; Sujuan Huang; Matthew J Ehrhardt; Nickhill Bhakta; Kirsten K Ness; Kevin R Krull; D Kumar Srivastava; Leslie L Robison; Melissa M Hudson; I-Chan Huang
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

8.  Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.

Authors:  F Bernard; P Auquier; I Herrmann; A Contet; M Poiree; F Demeocq; D Plantaz; C Galambrun; V Barlogis; J Berbis; F Garnier; N Sirvent; J Kanold; P Chastagner; H Chambost; G Michel
Journal:  Bone Marrow Transplant       Date:  2014-02-17       Impact factor: 5.483

9.  Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood.

Authors:  Pauline Girard; Pascal Auquier; Vincent Barlogis; Audrey Contet; Maryline Poiree; François Demeocq; Julie Berbis; Iris Herrmann; Virginie Villes; Nicolas Sirvent; Justyna Kanold; Pascal Chastagner; Hervé Chambost; Dominique Plantaz; Gérard Michel
Journal:  Haematologica       Date:  2013-05-03       Impact factor: 9.941

10.  The quality of life of adult survivors of childhood hematopoietic cell transplant.

Authors:  J E Sanders; P A Hoffmeister; B E Storer; F R Appelbaum; R F Storb; K L Syrjala
Journal:  Bone Marrow Transplant       Date:  2009-08-31       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.